Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# veramed.online-preview.me

## Sitemaps
[XML Sitemap](https://veramed.com/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [AI in Clinical Research: From Hype to Impact](https://veramed.com/resources/ai-in-clinical-research/): How life sciences organizations can adopt AI responsibly to deliver immediate value while building toward lasting transformation.
- [VeraViz: Providing clarity and real-time data visibility through customized data visualizations and dashboards](https://veramed.com/resources/customized-data-visualizations-and-dashboards/): A customized platform for data visualization was implemented to give a biotech secure, customized dashboards that improved medical monitoring, reduced manual effort, and enabled faster, better-informed decision-making.
- [Not Just Another Estimands Blog: Why Communication Is the Missing Piece](https://veramed.com/resources/estimands-why-communication-is-the-missing-piece/): Top tips for statisticians communicating estimands in terms our study teams care about: patients and clinical outcomes.
- [The Biostatistics Advantage: 5 Questions to Drive Clinical Success  ](https://veramed.com/resources/the-biostatistics-advantage-5-questions-to-drive-clinical-success/): Leaders across clinical development face unprecedented challenges, where success hinges on making high-stakes decisions in a complex environment. What questions should you be asking your biostatistics partner to achieve strategic advantages? Discover here.
- [Love it or HTA it: Exploring Variability in Submission Requirements & Implications for Global Strategy](https://veramed.com/resources/exploring-variability-in-submission-requirements/): Navigate global HTA requirements with expert insights on NICE, G-BA, and HAS. Learn how biostatistics, HEOR, and clinical trial design support market access success.
- [Double Trouble: Tackling Expectations, Challenges & AI in Double Programming](https://veramed.com/resources/tackling-expectations-challenges-ai-in-double-programming/): Optimize clinical trial design with expert biostatistics and biometrics insights. Learn how to balance complexity, cost and efficiency for successful drug development.
- [Shaping Europe’s Demographic Future: The Role of Clinical Trials](https://veramed.com/resources/shaping-europes-demographic-future-the-role-of-clinical-trials/): Explore how demographic analysis improves clinical trial design. Learn how biostatistics, PCA, and real-world data shape recruitment and biotech strategy in Europe.
- [Arm Wrestling with Uncertainty: Meta-Analysis for Survival Estimation](https://veramed.com/resources/meta-analysis-for-survival-estimation/): Strengthen clinical trial design with meta-analysis for survival estimation. Learn how biometrics and biostatistics improve Phase 3 success and reduce trial risk.
- [Walking the Tightrope: Balancing the Needs of All Stakeholders for Biotech Survival](https://veramed.com/resources/balancing-the-needs-of-all-stakeholders-for-biotech-survival/): Optimize biotech survival with expert clinical trial design insights from Toby Batten. Learn how biostatistics and biometrics CROs balance cost, risk, and success.
- [Bayesian Building Blocks: The Key to Successful Validation](https://veramed.com/resources/bayesian-building-blocks/): Learn how Bayesian analysis improves clinical trial design. Insights from Moaaz Sidat on adaptive trials, biometrics, and biostatistics for biotech success.
- [World Blood Donor Day: Why Donor Diversity is Critical for Sickle Cell Care](https://veramed.com/resources/world-blood-donor-day-why-donor-diversity-is-critical-for-sickle-cell-care/): As we mark World Blood Donor Day on 14 June, it is an opportunity to highlight why donor diversity matters.
- [Season 2 Episode 003 – It’s Just Good Science: Why Inclusive Clinical Trials Matter](https://veramed.com/resources/season-2-episode-003-its-just-good-science-why-inclusive-clinical-trials-matter/): In this podcast, we explore why diversity, equity and inclusion in clinical research is not just an ethical consideration, but a scientific necessity. Zoe Kefford and Roxanne McGuire discuss real-world examples of underrepresentation, the risks of incomplete data, and the critical roles of transparency and early diagnosis in improving outcomes.
- [One CRO, One Workflow: How Integrated Data Management and Biostatistics Services Streamline Clinical Trials](https://veramed.com/resources/one-cro-one-workflow-how-integrated-data-management-and-biostatistics-services-streamline-clinical-trials/): In such a high-pressure landscape, sponsors must look for ways to deliver trials faster, more efficiently, and with uncompromising data quality. 
- [AI in Biometrics in 2026: Enterprise Change & Skills Guide](https://veramed.com/resources/ai-in-biometrics-2026-enterprise-change/): Get expert insights into how AI is transforming biometrics and what your organization needs to do now to lay the groundwork for larger-scale implementation.
- [Season 2 Episode 002 – Meet the ELT: Troy McCall](https://veramed.com/resources/season-2-episode-002-meet-the-elt-troy-mccall/): In this episode, CEO Troy McCall shares an open, insightful look into his leadership journey, what drew him to Veramed, and how his first impressions evolved into a deep belief in the power of our culture and quality.
- [Season 2 Episode 001 – The Voices Behind the Mic](https://veramed.com/resources/season-2-episode-001-the-voices-behind-the-mic/): The Veramed Podcast is officially back for Season 2! With our new identity and an international team of hosts, Veramed Stories will bring listeners a mix of conversations, expert insights and diverse voices throughout 2026.
- [Beating the Clock: How Strategic Data Management Enabled an Early Database Lock ](https://veramed.com/resources/beating-the-clock-how-strategic-data-management-enabled-an-early-database-lock/): When a global leader in aerosol drug delivery technologies initiated a Phase 2 clinical trial for its respiratory therapy under tight timelines, a strategic approach to data management was essential.
- [Driving Outcomes Through Strategic Oversight: Best Practices in Clinical Data Management](https://veramed.com/resources/best-practices-in-clinical-data-management/): Effective data management oversight must address both technical and compliance aspects. In this blog, we explore strategic approaches to tackle clinical data management challenges.
- [Culture as a competitive edge: Veramed’s signature people-first approach ](https://veramed.com/resources/culture-as-a-competitive-edge-verameds-signature-people-first-approach/): Veramed was reaccredited as a 3-star Best Companies workplace in November 2025. In an industry where consistency, collaboration, and retention are critical, Veramed’s people-first CRO approach offers sponsors a strategic advantage.
- [The Veramed Signature: Setting the new standard in biometrics ](https://veramed.com/resources/the-veramed-signature-setting-the-new-standard-in-biometrics/): With a fresh new Veramed brand, our CEO, Troy McCall, discusses the company's mission and our ongoing commitment to the highest standards.  
- [Detective Work in Data: A Case Study in CDISC Conversion Excellence](https://veramed.com/resources/detective-work-in-data-a-case-study-in-cdisc-conversion-excellence/): With outdated and incomplete datasets, Veramed helped a biotech client convert its legacy clinical trial data to CDISC-compliants formats.
- [Delivering Cost-Efficient, Scalable FSP Solutions for a Top 10 Global Pharma](https://veramed.com/resources/delivering-cost-efficient-scalable-fsp-solutions-for-a-top-10-global-pharma/): Building on a strong partnership of over a decade, Veramed's adaptable FSP solutions enabled a global Pharma client to exceed its strategic objectives.
- [The Evolution of the Data Manager Role in Clinical Trials: Part 2 – Inter-Trial Relationships, Growing Complexity and Anticipating the Future](https://veramed.com/resources/the-evolution-of-the-data-manager-role-in-clinical-trials-part-2-inter-trial-relationships-growing-complexity-and-anticipating-the-future/): In the second of this two-part series, we’ll explore the relationship between data managers and statisticians in clinical trials, the responsibility of data managers for facilitating the implementation of novel trial designs, and how they maintain quality through good clinical data management practices as technology and trial designs become more complex. Jorge Torres Borrero, Senior Clinical Data Manager, shares his insights
- [Which FSP Model is Right For You?](https://veramed.com/resources/which-fsp-model-is-right-for-you/): Different clients can have very different needs, and this means that when it comes to choosing a functional service provider, it’s important to choose the one that will offer you the right support for your business.
- [Veramed Announces Appointment of Anna Hayes as Senior Director for Data Management](https://veramed.com/resources/veramed-announces-appointment-of-anna-hayes-as-senior-director-for-data-management/): Veramed is pleased to announce the appointment of Anna Hayes as Senior Director for Data Management. With nearly 20 years of experience in the CRO industry, Anna brings a proven track record of leading strategic biometrics partnerships. Her work has consistently helped clients accelerate data reporting and enhance data quality and integrity, always with a focus on scalable, high-impact outcomes.
- [Veramed: Global Workforce in Action](https://veramed.com/resources/veramed-global-workforce-in-action-2-2/): If the last five years have taught us anything, it’s that the best people for a specific role or responsibility within an organization aren’t necessarily on your doorstep.  The rise in working-from-home also thrust a previously rare working format into the foreground – remote working.  
- [Veramed Announces CEO Transition as Company Enters Next Phase of Global Growth](https://veramed.com/resources/veramed-announces-ceo-transition/): Veramed, a leading provider of biometrics services to the pharmaceutical and biotech industries, today announced a strategic leadership transition as part of its continued global expansion. Founder and current CEO Matthew Jones will step into a new role focused on innovation, while seasoned industry executive Troy McCall has been appointed as the company’s new Chief Executive Officer.This founder-inspired transition is fully supported by Veramed’s leadership team and reflects the company’s commitment to scaling its values-driven culture while meeting the demands of a growing, global client base.
- [Q-TWiST in Oncology: A Patient-Centric View of Benefit-Risk](https://veramed.com/resources/q-twist-in-oncology-a-patient-centric-view-of-benefit-risk/): We help to transform complex clinical data into meaningful, patient-focused insights. In a recent post-marketing initiative, our Evidence & Value Generation (EVG) team applied the Q-TWiST methodology to evaluate a novel oncology treatment—delivering a compelling narrative around benefit-risk balance.
- [Driving Precision in Real-World Evidence: MAIC in Endometrial Cancer](https://veramed.com/resources/driving-precision-in-real-world-evidence-maic-in-endometrial-cancer/): We ran a complex Comparative Effectiveness project as part of the value demonstration of an immunotherapy medicine in advanced endometrial cancer. The project employed the Match-Adjusted Indirect Comparison (MAIC) methodology, guided by NICE DSU TSD 18 to ensure adherence to guidelines. This approach bridges evidence gaps where head-to-head trials are absent, supports HTA submissions and reimbursement decisions, and delivers tailored solutions backed by scientific rigor and transparency.
- [Veramed Announces Appointment of Claude Price as Senior Director for Data Management](https://veramed.com/resources/veramed-announces-appointment-of-claude-price-as-senior-director-for-data-management/): Veramed is pleased to announce the appointment of Claude Price as Senior Director for Data Management. With over 23 years in the industry, Claude has led global teams across both Biometrics and Data Management, with extensive experience in executing large, submission-driven portfolios. His tenacity in finding new and exciting ways to innovate and onboard new technologies while successfully growing departments to meet the needs of clients will make him a valuable addition to our senior management team. This appointment marks a key step in strengthening our Data Management capabilities, as we continue to invest in and expand our leadership team to support our growing portfolio and client needs.In his new role, Claude will be responsible for leading the Data Management group within Veramed, ensuring the Data Management teams maintain their excellent standards and helping to grow client governance and maintain regulatory compliance. Claude will work closely with the entire Data Management team and all other departments, supporting Veramed’s consistent quality deliverables to their clients.  
- [Veramed Solidifies Expansion in India with New Headquarters in Bengaluru](https://veramed.com/resources/veramed-solidifies-expansion-in-india-with-new-headquarters/): Veramed is proud to announce the opening of its new India headquarters in Bengaluru, on 21 April 2025. This marks a significant step in the company’s ongoing expansion in the region.  Located in the heart of Bengaluru, the new headquarters will serve as a strategic base to further support Veramed’s global clients and partners while advancing the company’s ambitious growth objectives. The expanded office underscores Veramed’s commitment to building high-performing teams dedicated to quality and excellence. It will also act as a central hub for nurturing and developing local talent through Veramed’s industry-leading training and development programs.  The opening of Veramed’s new headquarters in India marks a major milestone in the company’s global growth journey, further strengthening its position as a leading specialist biometrics CRO. By adding local expertise and insights in India, Veramed is set to broaden its biometrics and data management capabilities, enhance operational efficiency, and deliver high-quality, tailored solutions to clients worldwide. This expansion reaffirms Veramed’s commitment to innovation, quality, and supporting the evolving needs of the pharmaceutical and biotech industries on a global scale.  
- [Understanding Globalization of Workforce: Benefits, Challenges and Strategies](https://veramed.com/resources/understanding-globalization-of-workforce-benefits-challenges-and-strategies/): How businesses operate and how people work has changed dramatically during the last decade, fuelled by exponential advances in modern technology and the COVID-19 pandemic which reshaped the potential for working from home and remote job roles.   
- [From Rescue to FDA Approval: Reanalysis and Resubmission of an Ophthalmology Trial](https://veramed.com/resources/from-rescue-to-fda-approval-reanalysis-and-resubmission-of-an-ophthalmology-trial/): This case study highlights an ophthalmology clinical trial for a product to treat wet age-related macular degeneration (AMD). “Wet” AMD is a rare type of macular degeneration, accounting for just 10% of overall cases. However, it’s an advanced form of the condition, causing rapid onset and severe vision loss. Currently, there are very limited treatment options available, making this trial extremely important.
- [Dealing with Reality: Using Regulatory and Biostatistics Strategies to Adapt to the Unexpected in Clinical Trials](https://veramed.com/resources/dealing-with-reality-using-regulatory-and-biostatistics-strategies-to-adapt-to-the-unexpected-in-clinical-trials/): Join Veramed’s Debra Anderson, SVP, Strategic Partnerships, Mark Holland, Head of Programming Delivery, and Facet Life Science’s Lisa Jenkins VanLuvanee, COO & VP, R&D and Jason Mercer, Regulatory Affairs Consultant, to discover actionable insights to help you respond to unexpected challenges in clinical trials with confidence.
- [From Risk to Rescue: When and why to engage a specialist CRO to recover your clinical trial](https://veramed.com/resources/risk-to-rescue-when-and-why-to-engage-a-specialist-cro-to-recover-your-clinical-trial/): Clinical outsourcing is an effective and cost-efficient way to harness the resources and experts needed to carry out successful clinical trials and advance modern medicine and healthcare. According to The New Trends of Global Clinical Development Outsourcing Market report, data collected between 2015 and 2020 estimated CRO outsourcing would account for 72% of all clinical trials, suggesting that nearly three in every four clinical trials are run by a professional CRO partner.
- [On Your Radar: Emerging Trends for the Biometrics Industry](https://veramed.com/resources/emerging-trends-for-the-biometrics-industry/): As we move through 2025 it’s clear that the biometrics industry is set to continue to transform at pace, with four key trends emerging that look set to shape the landscape over the coming months and years. Whether it’s adopting the latest generative AI strategies and automation, utilizing open-source platforms or simply investing in agile, high-quality teams, organizations will need to think and plan ahead if they are to remain competitive 
- [Planning for Success: Unlock Regulatory & Biometric Strategies for Clinical Trials](https://veramed.com/resources/planning-for-success-unlock-regulatory-biometric-strategies-for-clinical-trials/): Join Veramed’s Debra Anderson, SVP, Strategic Partnerships, Mark Holland, Head of Programming Delivery, and Facet Life Science’s Lisa Jenkins VanLuvanee, COO & VP, R&D and Jason Mercer, Regulatory Affairs Consultant, for an insightful webinar exploring the critical role of integrated regulatory and statistical planning in clinical trial success.
- [5 Core Skills of a Data Manager](https://veramed.com/resources/5-core-skills-of-a-data-manager/): As clinical research specialists, you know the importance of maintaining data accuracy, integrity, and compliance in clinical trials. In this article, we will explore the key skills necessary for effective clinical data management, helping you enhance the quality and reliability of your data and to optimize the success of your study.
- [The Evolution of the Data Manager Role in Clinical Trials: Part 1 – A Day in the Life of a Data Manager](https://veramed.com/resources/the-evolution-of-the-data-manager-role-in-clinical-trials-part-1-a-day-in-the-life-of-a-data-manager/): The role of a data manager has evolved considerably during the last few years. From primarily having responsibilities dedicated to one Electronic Data Collection system (EDC), such as collecting, securely storing, and ensuring the compliance of data, to today’s data managers having many more accountabilities. They play a vital role in supporting the smooth operation of any organization that captures and processes data, in any capacity and for any industry.
- [What is a Data Monitoring Committee and why does your organization need one?](https://veramed.com/resources/what-is-a-data-monitoring-committee-and-why-does-your-organization-need-one/): If you’ve worked in the pharma-biotech industry for a while, you’ve probably heard the term “data monitoring committee” or “DMC” around, but you might be unfamiliar with exactly what they mean. 
- [Veramed appoints Katherine Hutchinson as EVP of Alliance Management](https://veramed.com/resources/veramed-appoints-katherine-hutchinson-as-evp-of-alliance-management/): Specialist Biometrics CRO, Veramed, today announced that Katherine Hutchinson will be moving into a new role as EVP of Alliance Management, where she will continue to focus on delivering quality and excellence to Veramed’s customers and partners globally. Over the past 8 years, Katherine has played a crucial role in leading operations and has held the position of COO since 2022. During this time, she has successfully navigated Veramed through massive growth, and transformative change, whilst maintaining Veramed’s reputation as the industry’s CRO of choice
- [Veramed Completes B Corp™ Re-certification With Improved Score, Re-affirming Their Commitment to Social and Environmental Responsibility, Transparency and Ethical Practice ](https://veramed.com/resources/veramed-completes-b-corp-re-certification-with-improved-score-re-affirming-their-commitment-to-social-and-environmental-responsibility-transparency-and-ethical-practice/): Veramed is proud to announce that it has been re-certified as a Certified B Corporation™, re-affirming its ongoing commitment to using business as a force for good. As a B Corp™, they are part of a global community of businesses that meet high standards of social and environmental impact, and that prioritize positive influence alongside profitability.For the second time, Veramed exceeded the minimum requirement of 80 points for re-certification with an overall score of 94.8, achieving the highest scores in the Workers (35.2) and Governance (17.2) impact areas. Some 9,000 companies across 160 industries in over 100 countries have achieved B Corp™ certification. Veramed are looking forward to collaborating with more certified companies in their industry in the future.Since Veramed was B Corporation™ certified in 2020, it has grown from 160 to over 400 staff, and has added several new dimensions to their business, including additional geographies and entities, which were all evaluated and verified during the re-certification process. Throughout this growth phase, they have stayed true to their culture, which recognizes the value of putting their people and key stakeholders first. This is evidenced by one of the areas in which they demonstrated most improvement during the recertification process, the Workers Impact Area, which looks at contributions to employee’s financial security, health and safety, wellness, career development and satisfaction. In recent years they have formalized their Diversity, Equity and Inclusion policies and introduced a wide range of initiatives related to this through the Veramed Culture Club. The B Corp™ certification addresses all parts of a business’ operations covering five key impact areas of Governance, Workers, Community, Environment and Customers. The certification process is rigorous, with applicants required to reach a benchmark score of 80 or above, while providing evidence of socially and environmentally responsible practices relating to energy supplies, waste and water use, worker compensation, diversity and corporate transparency. To complete the certification, each business must amend their governing documentation to consider stakeholder interests alongside shareholder profits. And for total transparency, B Corp™ certified companies must publish their impact report, sharing their performance with the public.Becoming a Certified B Corp™ in 2020 gave Veramed a benchmark across the five key B Corp™ pillars. These pillars now act as cornerstones of their organization and are the foundation from which they make decisions and agree on initiatives. Their successful recertification is illustrative of continued commitment to considering all stakeholders, including workers, customers, the community and environment, as the organization continues to grow.
- [Weather, Elections and Clinical Trials: Some Novel Approaches to Visualizing Uncertainty](https://veramed.com/resources/weather-elections-and-clinical-trials-some-novel-approaches-to-visualizing-uncertainty/): This animation is known as a Hypothetical Outcome Plot (HOP) which can be effective in communicating inferential uncertainty to an audience without statistical training. Such novel data visualization methods are common in fields such as election forecasting and hurricane prediction, but quite underutilised in clinical trial reporting.
- [The Road to Automation: what is an automation health check?](https://veramed.com/resources/the-road-to-automation-what-is-an-automation-health-check/): The healthcare industry is in the midst of an Automation revolution. A sudden swarm of attention has been thrust on the sector renowned for increasing trial efficiencies due to the rise of Artificial Intelligence (AI). As a burgeoning technology and branch of Automation, AI goes beyond traditional, rule-based automation to simulate human intelligence. Its potential impact on trial efficiencies and the quality of insights is raising eyebrows.In 2024, both big pharma and a growing sector of biotech companies are waking up to Automation’s promise. As a result, the pressure to adopt, integrate and proactively get ahead of this incoming wave of efficiency is altering the way companies approach their trials and outsourcing strategies.
- [Navigating CRO Oversight Challenges in Clinical Data Management: A Technical Perspective](https://veramed.com/resources/navigating-cro-oversight-challenges-in-clinical-data-management-a-technical-perspective/): In clinical research, Contract Research Organizations (CROs) play a pivotal role in managing and executing various aspects of trials. Among these responsibilities, clinical data management stands out as a critical function: ensuring the integrity, quality, and compliance of clinical trial data. However, overseeing CROs in their clinical data management deliverables presents a unique set of challenges that demand attention and strategic solutions. In this blog post, we delve into the main challenges faced in CRO oversight for clinical data management deliverables and explore potential strategies to address them effectively.
- [Mastering the Art of Coordinating External Data Sources in Clinical Data Management](https://veramed.com/resources/mastering-the-art-of-coordinating-external-data-sources-in-clinical-data-management/): In today's dynamic landscape of clinical research, integrating external data sources is of critical importance to enrich the depth of clinical trial data and offer valuable insights into patient treatments. From electronic health records (EHRs) to genomic data and real-world evidence, these diverse sources hold immense potential to propel drug development forward. Yet, orchestrating these data streams presents formidable challenges for seasoned professionals in clinical data management. 
- [Streamlining Clinical Trials: Why Packaging Data Management and Statistical Services with a Single CRO Makes Sense](https://veramed.com/resources/streamlining-clinical-trials-why-packaging-data-management-and-statistical-services-with-a-single-cro-makes-sense/): As a seasoned professional with years of experience in the clinical research field, I’ve seen firsthand how vital it is to keep our processes efficient and our data impeccable. One of the most effective strategies I’ve encountered is to outsource Clinical Data Management (CDM) with Statistics and Statistical Programming services under one Contract Research Organization (CRO). 
- [Veramed appoints Dan Ryalls as Chief Financial Officer](https://veramed.com/resources/veramed-appoints-dan-ryalls-as-chief-financial-officer/): We are excited to announce that Dan Ryalls has been appointed as Chief Financial Officer (CFO) of Veramed.  Dan's strategic leadership will play a pivotal role in guiding Veramed’s growth trajectory as the company expands services and broadens its global footprint.
- [The Bayesian Edge in Clinical Trials: From Prior Knowledge to Better Informed Outcomes](https://veramed.com/resources/the-bayesian-edge-in-clinical-trials-from-prior-knowledge-to-better-informed-outcomes/): Traditionally the use of Bayesian analysis in clinical research has been restricted by concerns over how easily it can be understood by statistically non-technical colleagues or how regulatory authorities would receive the results. However, the use of Bayesian study designs and analysis methods have become increasingly popular due to communications from regulatory authorities such as the FDA, and the advantages over frequentist methods such as greater cost-effectiveness and flexibility in trial design it can offer in some situations.
- [Aiding decision making in interim analyses using predictive probabilities derived by results from Bayesian MMRMs](https://veramed.com/resources/aiding-decision-making-in-interim-analyses-using-predictive-probabilities-derived-by-results-from-bayesian-mmrms/): READ FULL PAPER DOWNLOAD CODE DOWNLOAD DUMMY DATA VIEW REFERENCED PAPER

## Pages
- [Veramed Scrabble Submission](https://veramed.com/veramed-scrabble-form-submission/): Please submit your scrabble score here to be in with a chance of winning a prize! You will be contacted via email if you have won.
- [Right‑First‑Time Biometrics for Early Phase Biotech Trials | Veramed](https://veramed.com/right-first-time-biometrics/): Discover how early biometrics decisions can make or break biotech clinical trials. Expert insights on data management, statistics and right‑first‑time delivery.
- [Thank You – PHUSE US Form](https://veramed.com/thank-you-phuse-us-form/): Thanks for submission.
- [PHUSE US Form](https://veramed.com/phuse-us-form/): Please fill in your details and a member of our team will reach out and share more information on Veramed's tailored solutions.
- [Thank You – PHUSE APAC Form](https://veramed.com/thank-you-phuse-apac/): Thanks for submission.
- [PHUSE APAC Form](https://veramed.com/phuse-apac-form/): Please fill in your details and a member of our team will reach out and share more information on Veramed's tailored solutions.
- [Job Detail](https://veramed.com/job-detail/)
- [Job Openings](https://veramed.com/job-openings/): If you’re seeking expert biometrics support, need clarity and confidence in your data, or are inspired to help shape the future of next-generation CRO services, connect with us today.
- [KRIs and QTLs Download](https://veramed.com/kris-and-qtls-download/): Delivering submission-ready data with confidence.
- [Candidate Privacy Policy](https://veramed.com/candidate-privacy-policy/): You are being sent a copy of this privacy notice because you are applying for work with us (whether as an employee, worker or contractor). This notice sets out how Veramed Limited uses and protects your personal information during the recruitment process. It provides you with certain information that must be provided under the UK General Data Protection Regulation (UK GDPR).
- [Thank You – PSI Careers Page](https://veramed.com/thank-you-psi-careers-page/): Thanks for submission.
- [PSI Careers Page](https://veramed.com/psi-careers-page/): Please fill in your details to register your interest in our Graduate Training Program
- [Thank You – Newsletter](https://veramed.com/thank-you-newsletter/): Thanks for submission.
- [Thank You – Talent Community](https://veramed.com/thank-you-talent-community/): Thanks for submission.
- [Terms and Conditions](https://veramed.com/terms-and-conditions/): Welcome to our website. If you continue to browse and use this website, you are agreeing to comply with and be bound by the following terms and conditions of use, which together with our privacy policy govern Veramed’s relationship with you in relation to this website. If you disagree with any part of these terms and conditions, please do not use our website.
- [CV thank you](https://veramed.com/cv-thank-you/): Please fill in the form below and attach your CV in the next step so we can keep your details on file. We will be in touch with any suitable job opportunities
- [Graduate Training Program Ukraine](https://veramed.com/careers/graduate-training-program-ukraine/): Applications for our Ukraine Graduate Program are currently closed.
- [Graduate Training Program UK](https://veramed.com/careers/graduate-training-program-uk/): Applications open on 17th November 2025 for an October 2026 start
- [Programmer Hub](https://veramed.com/careers/programmer-hub/): Become part of a next generation CRO
- [Statistician Hub](https://veramed.com/careers/statistician-hub/): Become part of a next generation CRO
- [Ukraine Careers](https://veramed.com/careers/ukraine-careers/): Become part of a next generation CRO
- [Germany Careers](https://veramed.com/careers/germany-careers/): Become part of a next generation CRO
- [Who We Service](https://veramed.com/who-we-service/)
- [Company](https://veramed.com/company/)
- [Thank You](https://veramed.com/thank-you/): Thanks for submission, we'll get back to you shortly.
- [Large Pharma](https://veramed.com/who-we-service/large-pharma/): Scalable biometrics solutions, operational excellence, and cost efficiency in a complex global landscape
- [Small-Mid Sized Pharma](https://veramed.com/who-we-service/small-mid-sized-pharma/): Flexible expertise, first-class communication, and quality-driven solutions
- [Upload CV 02](https://veramed.com/careers/upload-cv-02/): Thanks for filling out the form, you can drop your CV below.
- [Sub Processor List](https://veramed.com/sub-processor-list/):  
- [Veramed Technical and Organisational Measures](https://veramed.com/technical-organisational-measures/): Company shall ensure the following:
- [Slavery Policy](https://veramed.com/slavery-policy/): Slavery and human trafficking statement
- [Code of Conduct](https://veramed.com/code-of-conduct/): Prevention of Sexual Harassment Policy
- [Privacy Policy](https://veramed.com/privacy-policy/): Last updated on: 25 September 2025 
- [Cookie Policy](https://veramed.com/cookie-policy/): This page explains the cookie policy of this website and provides information on the cookies used at this website.
- [Bcorp](https://veramed.com/company/bcorp/): Becoming a B Corp isn’t just about ticking boxes, it’s about doing business the right way. It means meeting high standards for social and environmental impact, transparency, and accountability.
- [Our Experts](https://veramed.com/company/our-experts/): Our leaders set the standard for biometrics, combining clarity, consistency and conviction to deliver impact at every level
- [Oncology](https://veramed.com/therapeutic-areas/oncology/): Comprehensive biometrics support to help you deliver high‑quality, regulatory‑ready outputs and bring life‑changing therapies to patients faster. 
- [Respiratory](https://veramed.com/therapeutic-areas/respiratory/): Expert biometrics support to improve the speed and success of your respiratory trials  
- [Rare Disease](https://veramed.com/therapeutic-areas/rare-disease/): Get expert biometrics support to overcome challenges, speed up timelines, and deliver rare disease breakthroughs. 
- [Biotech](https://veramed.com/who-we-service/biotech/): Personalized biometrics expertise, speed, and care to accelerate your success
- [Template | Generic content](https://veramed.com/template-generic-content/): Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
- [Video Background test](https://veramed.com/video-background-test/): EXPLORE SERVICES Speak to an Expert
- [Pages for QA](https://veramed.com/pages-for-qa/): Core Templates Homepage Leadership Careers About Services Delivery Models Sub Service Template Therapeutic Areas Resources Post Template Contact Child Specialist Area Template
- [Resources](https://veramed.com/resources/): Your guide to the industry and our role at 
its cutting edge.
- [Contact](https://veramed.com/contact/): If you’re seeking expert biometrics support, need clarity and confidence in your data, or are inspired to help shape the future of next-generation CRO services, connect with us today.
- [Therapeutic Areas](https://veramed.com/therapeutic-areas/): Advancing clinical research across critical therapeutic areas.
- [Careers](https://veramed.com/careers/): Become part of a next generation CRO
- [About](https://veramed.com/company/about-us/): We're a CRO that brings the right minds to every project, with experts in every department and expertise in every decision. Agile, scalable and solution-oriented, we adapt to what our clients need when they need it.
- [Services](https://veramed.com/services/): Flexible, tailored biometrics services to increase the success of your clinical trials and get therapies to market faster.
- [Solutions](https://veramed.com/solutions/): When and where you need them most.

## Discover
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services-copy/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services-2-copy/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services-3-copy/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services-3/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services-2/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.
- [Strategic & Technical Consulting Services](https://veramed.com/resources/discover/strategic-technical-consulting-services/): Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat.

## Services
- [CDISC](https://veramed.com/services/standards-innovation-ai/cdisc/): Enabling sustainable, compliant, and scalable clinical data excellence.
- [Tools & Tech Enablement](https://veramed.com/services/standards-innovation-ai/tools-tech-enablement/): Accelerate study success: automate workflows, future-proof results, and streamline delivery.
- [R & Open Source](https://veramed.com/services/standards-innovation-ai/r-open-source/): Validated, R, open-source and cloud solutions for transparent, compliant, and efficient analytics.
- [Next Generation Standards](https://veramed.com/services/standards-innovation-ai/next-generation-standards/): Future-proof your data standards strategy.
- [Data Visualization](https://veramed.com/services/standards-innovation-ai/data-visualization/): Make faster, smarter decisions with live trial insights.
- [Veramed.AI](https://veramed.com/services/standards-innovation-ai/veramed-ai/): Harness AI to improve efficiency and accuracy in biometrics workflows
- [End-to-End Automation](https://veramed.com/services/standards-innovation-ai/end-to-end-automation/): Improve the efficiency of your clinical trial workflows.
- [Standards, Innovation & AI](https://veramed.com/services/standards-innovation-ai/): Unlock the full potential of automation, advanced analytics, and technology & AI enablement
- [Programming](https://veramed.com/services/programming/): Accurate insights for successful regulatory approval.
- [Evidence & Value Generation](https://veramed.com/services/evidence-value-generation/): The right evidence at the right time and in the right format. 
- [Data Management](https://veramed.com/services/data-management/): Delivering submission-ready data with confidence.
- [Biostatistics](https://veramed.com/services/biostatistics/): Design better trials, ensure compliance, produce clear results.
- [Template Child Specialist Area Template](https://veramed.com/services/template-child-specialist-area-template/): Accelerate Study Success: Automate Workflows, Future-Proof Results, and Streamline Delivery.
- [Template Sub Service Template](https://veramed.com/services/template-sub-service-template/): Unlock the Full Potential of Automation, Advanced Analytics, and Technology & AI Enablement

## Solutions
- [Flex Solutions](https://veramed.com/solutions/project-based-solutions/flex-solutions/): We deliver rapid, end‑to‑end biometrics solutions for complex and time‑critical studies, ensuring quality and delivery certainty.
- [Project-Based Solutions](https://veramed.com/solutions/project-based-solutions/): Flexible, high-quality biometrics solutions to support clinical trials from start to finish.
- [Project Portfolio](https://veramed.com/solutions/project-based-solutions/project-portfolio/): We offer unified portfolio oversight and dedicated support from a consistent team, ensuring seamless project continuity, simplified management, and communication tailored to your needs.
- [Rescue & Transition of Vendors](https://veramed.com/solutions/project-based-solutions/rescue-transition-of-vendors/): We deliver tailored rescue and vendor transition services, performing expert technology assessments to identify risks, ensure system compatibility, and realign programs for study success.
- [Data Monitoring Committees](https://veramed.com/solutions/project-based-solutions/data-monitoring-committee/): We provide independent, expert DMC services that safeguard patient safety, protect study integrity, and deliver timely, compliant analyses.
- [Integrated Analysis & Submission](https://veramed.com/solutions/project-based-solutions/integrated-analysis-submission/): We deliver seamless integrated analyses and submission-ready outputs, helping you meet global regulatory requirements efficiently and with confidence.
- [End-to-End Biometrics](https://veramed.com/solutions/project-based-solutions/end-to-end-biometrics/): We manage the full biometrics lifecycle, from study design to final submission, ensuring quality, efficiency, and smooth delivery.
- [Single Service Biometrics](https://veramed.com/solutions/project-based-solutions/single-service-biometrics/): We offer flexible single-service biometrics solutions that seamlessly integrate with your clinical teams and other vendors, ensuring collaboration and clear communication to keep your studies on track.
- [FSP Hybrid](https://veramed.com/solutions/functional-service-provider/fsp-hybrid/): Blended Outsourcing Solutions with Expert Governance to drive efficiencies and communication.
- [Project Portfolio FSP](https://veramed.com/solutions/functional-service-provider/project-portfolio-fsp/): Unified oversight and solid support from a ring-fenced Veramed team.
- [FSP Team Model](https://veramed.com/solutions/functional-service-provider/fsp-team-model/): A fully integrated FSP relationship, that minimises your oversight for streamlined, hands-off efficiency.
- [FSP Classic](https://veramed.com/solutions/functional-service-provider/fsp-classic/): A fully integrated augmented staffing partnership, strategically placing top talent on your studies with expert planning and oversight.
- [Specialist FSP](https://veramed.com/solutions/functional-service-provider/specialist-fsp/): Targeted, short-term support to fill skills gaps.
- [Technology & AI](https://veramed.com/solutions/strategic-technical-consulting/technology-ai/): Accelerate Study Success: Automate Workflows, Future-Proof Results, and Streamline Delivery.
- [Statistical Consultancy](https://veramed.com/solutions/strategic-technical-consulting/statistical-consultancy/): Flexible and collaborative statistical support, from study to submission, and beyond  
- [Functional Service Provider](https://veramed.com/solutions/functional-service-provider/): Powering long-term success through close collaboration and bespoke integrated solutions.
- [Strategic & Technical Consulting](https://veramed.com/solutions/strategic-technical-consulting/): Specialized guidance across statistical design, data management, programming, and technology solutions
- [Template | Project based solutions](https://veramed.com/solutions/template-project-based-solutions/): Flexible, high-quality biometrics solutions to support clinical trials from start to finish.